TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
EXOZ

eXoZymes, Inc.

Healthcare · Biotechnology

6.30$ -0.7% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EXOZ
Line item 2021 2022 2023 2024 2025
– +14.5% +32.5% +266.3% -54.2%
– +40.4% -17.4% +791.6% -63.6%
– +2.0% -88.1% +14,508.3% -68.7%
– +2.0% -88.1% +14,508.3% -68.7%
– +72.8% +9.0% -16.4% -29.8%
– +14.3% +200.3% -33.7% -1.5%
– +58.3% +280.7% -44.8% +17.5%
– +8.6% +55.2% +2.2% +41.8%
– +44.3% +82.2% +31.5% +33.7%
– +14.7% -128.0% – -67.4%
– – – – –
– +0.0% +0.0% +0.0% +3.1%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?